Pharma Foods International Co., Ltd. (2929.T)
JPY 934.0
(-0.43%)
JPY 934.0
(-0.43%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 16.89 Billion JPY | -15.95% |
| 2023 | 20.09 Billion JPY | 19.21% |
| 2022 | 16.85 Billion JPY | 244.23% |
| 2021 | 4.89 Billion JPY | 36.84% |
| 2020 | 3.57 Billion JPY | 15.17% |
| 2019 | 3.1 Billion JPY | 119.95% |
| 2018 | 1.41 Billion JPY | -10.84% |
| 2017 | 1.58 Billion JPY | 133.39% |
| 2016 | 678.87 Million JPY | 35649.13% |
| 2015 | 1.89 Million JPY | -55.54% |
| 2014 | 4.27 Million JPY | -97.91% |
| 2013 | 204.67 Million JPY | -0.37% |
| 2012 | 205.43 Million JPY | 2575.34% |
| 2011 | 7.67 Million JPY | -74.34% |
| 2010 | 29.92 Million JPY | -53.81% |
| 2009 | 64.79 Million JPY | -29.87% |
| 2008 | 92.39 Million JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 19.14 Billion JPY | -3.83% |
| 2024 Q4 | 16.89 Billion JPY | -11.76% |
| 2024 Q1 | 20.16 Billion JPY | 0.36% |
| 2024 Q2 | 19.9 Billion JPY | -1.3% |
| 2023 Q1 | 18.62 Billion JPY | 10.46% |
| 2023 FY | 20.09 Billion JPY | 19.21% |
| 2023 Q2 | 20.43 Billion JPY | 9.76% |
| 2023 Q3 | 20.31 Billion JPY | -0.62% |
| 2023 Q4 | 20.09 Billion JPY | -1.06% |
| 2022 FY | 16.85 Billion JPY | 244.23% |
| 2022 Q3 | 14.65 Billion JPY | 57.53% |
| 2022 Q4 | 16.85 Billion JPY | 15.0% |
| 2022 Q1 | 12.69 Billion JPY | 159.32% |
| 2022 Q2 | 9.3 Billion JPY | -26.73% |
| 2021 Q2 | 5.53 Billion JPY | -5.45% |
| 2021 Q4 | 4.89 Billion JPY | -4.39% |
| 2021 FY | 4.89 Billion JPY | 36.84% |
| 2021 Q1 | 5.85 Billion JPY | 63.6% |
| 2021 Q3 | 5.12 Billion JPY | -7.48% |
| 2020 Q3 | 3.76 Billion JPY | 45.98% |
| 2020 Q1 | 2.84 Billion JPY | -8.55% |
| 2020 FY | 3.57 Billion JPY | 15.17% |
| 2020 Q2 | 2.57 Billion JPY | -9.35% |
| 2020 Q4 | 3.57 Billion JPY | -4.84% |
| 2019 Q4 | 3.1 Billion JPY | 34.99% |
| 2019 FY | 3.1 Billion JPY | 119.95% |
| 2019 Q1 | 2.63 Billion JPY | 86.84% |
| 2019 Q2 | 2.43 Billion JPY | -7.61% |
| 2019 Q3 | 2.3 Billion JPY | -5.61% |
| 2018 Q1 | 1.48 Billion JPY | -6.36% |
| 2018 Q3 | 1.57 Billion JPY | 15.88% |
| 2018 Q2 | 1.36 Billion JPY | -8.26% |
| 2018 FY | 1.41 Billion JPY | -10.84% |
| 2018 Q4 | 1.41 Billion JPY | -10.43% |
| 2017 Q4 | 1.58 Billion JPY | -8.36% |
| 2017 FY | 1.58 Billion JPY | 133.39% |
| 2017 Q1 | 719.42 Million JPY | 5.97% |
| 2017 Q2 | 1.8 Billion JPY | 151.28% |
| 2017 Q3 | 1.72 Billion JPY | -4.36% |
| 2016 FY | 678.87 Million JPY | 35649.13% |
| 2016 Q1 | 818.88 Million JPY | 43022.12% |
| 2016 Q2 | 772.21 Million JPY | -5.7% |
| 2016 Q3 | 725.54 Million JPY | -6.04% |
| 2016 Q4 | 678.87 Million JPY | -6.43% |
| 2015 Q1 | 1.32 Million JPY | -68.91% |
| 2015 Q3 | 929 Thousand JPY | -17.71% |
| 2015 Q4 | 1.89 Million JPY | 104.41% |
| 2015 Q2 | 1.12 Million JPY | -14.98% |
| 2015 FY | 1.89 Million JPY | -55.54% |
| 2014 Q2 | 201.92 Million JPY | -0.1% |
| 2014 FY | 4.27 Million JPY | -97.91% |
| 2014 Q4 | 4.27 Million JPY | 147.31% |
| 2014 Q3 | 1.72 Million JPY | -99.14% |
| 2014 Q1 | 202.12 Million JPY | -1.25% |
| 2013 Q3 | 202.52 Million JPY | -0.1% |
| 2013 Q4 | 204.67 Million JPY | 1.06% |
| 2013 FY | 204.67 Million JPY | -0.37% |
| 2013 Q1 | 202.92 Million JPY | -1.22% |
| 2013 Q2 | 202.72 Million JPY | -0.1% |
| 2012 Q3 | 203.32 Million JPY | -0.1% |
| 2012 FY | 205.43 Million JPY | 2575.34% |
| 2012 Q1 | 3.72 Million JPY | -51.54% |
| 2012 Q4 | 205.43 Million JPY | 1.04% |
| 2012 Q2 | 203.52 Million JPY | 5369.55% |
| 2011 Q1 | 16.11 Million JPY | -46.14% |
| 2011 Q4 | 7.67 Million JPY | 0.0% |
| 2011 FY | 7.67 Million JPY | -74.34% |
| 2011 Q3 | - JPY | -100.0% |
| 2011 Q2 | 8.22 Million JPY | -48.95% |
| 2010 Q1 | 53.69 Million JPY | -17.12% |
| 2010 Q3 | 31.89 Million JPY | -30.37% |
| 2010 FY | 29.92 Million JPY | -53.81% |
| 2010 Q4 | 29.92 Million JPY | -6.19% |
| 2010 Q2 | 45.8 Million JPY | -14.69% |
| 2009 Q3 | 67.74 Million JPY | -15.49% |
| 2009 Q2 | 80.16 Million JPY | 0.0% |
| 2009 Q4 | 64.79 Million JPY | -4.35% |
| 2009 FY | 64.79 Million JPY | -29.87% |
| 2008 FY | 92.39 Million JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Takeda Pharmaceutical Company Limited | 4843.75 Billion JPY | 99.651% |
| Sumitomo Pharma Co., Ltd. | 418.88 Billion JPY | 95.968% |
| Shionogi & Co., Ltd. | 11.62 Billion JPY | -45.361% |
| Wakamoto Pharmaceutical Co.,Ltd. | 100.52 Million JPY | -16702.117% |
| Nippon Shinyaku Co., Ltd. | 2.87 Billion JPY | -488.127% |
| Kaken Pharmaceutical Co., Ltd. | 3.85 Billion JPY | -338.727% |
| Eisai Co., Ltd. | 206.74 Billion JPY | 91.83% |
| Morishita Jintan Co., Ltd. | 425 Million JPY | -3874.353% |
| Hisamitsu Pharmaceutical Co., Inc. | 2.1 Billion JPY | -704.333% |
| Mochida Pharmaceutical Co., Ltd. | 369 Million JPY | -4477.507% |
| Fuso Pharmaceutical Industries,Ltd. | 12.72 Billion JPY | -32.77% |
| Nippon Chemiphar Co., Ltd. | 16.98 Billion JPY | 0.53% |
| Tsumura & Co. | 79.69 Billion JPY | 78.804% |
| Kissei Pharmaceutical Co., Ltd. | 1.72 Billion JPY | -878.054% |
| Torii Pharmaceutical Co., Ltd. | 244 Million JPY | -6822.541% |
| Towa Pharmaceutical Co., Ltd. | 202.35 Billion JPY | 91.653% |
| Fuji Pharma Co., Ltd. | 28.94 Billion JPY | 41.651% |
| Zeria Pharmaceutical Co., Ltd. | 47.58 Billion JPY | 64.504% |
| KYORIN Holdings, Inc. | 20.94 Billion JPY | 19.359% |
| Taiko Pharmaceutical Co.,Ltd. | 3.8 Billion JPY | -343.45% |
| Daito Pharmaceutical Co.,Ltd. | 8.71 Billion JPY | -93.726% |
| SymBio Pharmaceuticals Limited | - JPY | -Infinity% |
| MedRx Co., Ltd | - JPY | -Infinity% |
| Mizuho Medy Co.,Ltd. | - JPY | -Infinity% |
| Solasia Pharma K.K. | 60 Million JPY | -28051.667% |
| Modalis Therapeutics Corporation | 412.5 Million JPY | -3994.788% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 9.48 Billion JPY | -78.081% |
| Sawai Group Holdings Co., Ltd. | 82.89 Billion JPY | 79.622% |
| Cyfuse Biomedical K.K. | 913 Million JPY | -1750.055% |
| Toho Holdings Co., Ltd. | 30.24 Billion JPY | 44.151% |
| Koa Shoji Holdings Co.,Ltd. | 2.82 Billion JPY | -497.851% |